Trials / Completed
CompletedNCT01552395
A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia
A Prospective Safety Study in 24 Months Treatment of Nocturia With Minirin Melt in Clinical Practice in the Czech Republic
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,136 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Confirmation of the Safety Profile for Minirin Melt in Clinical Practice
Conditions
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2012-03-13
- Last updated
- 2016-05-24
Locations
68 sites across 1 country: Czechia
Source: ClinicalTrials.gov record NCT01552395. Inclusion in this directory is not an endorsement.